Email
Text
WHAT IS THE PURPOSE OF THIS STUDY?
No medication is being tested in this study. Instead, the study is evaluating an alternative inhaler propellant that might be used in the future in medicines such as asthma inhalers. Most inhalers use a gas called a ‘propellant’ to deliver medication to the lungs. Usually, inhalers use a propellant called hydrofluoroalkane (HFA), which has a negative impact on the environment. This study is looking at an alternative propellant that uses hydrofluoroolefin (HFO). It works similarly to HFA by delivering medication to the lungs, but it has a much less negative environmental impact.
WHY SHOULD I PARTICIPATE?
Technologies to help slow the rate of climate change can only be developed because volunteers like you are willing to participate in studies like this one. You may not benefit directly through participation, but someone you know might benefit in the future.
WILL I BE PAID?
All study procedures and study-related medical care are provided at no cost. In addition, you will be compensated for your time and travel. Ask the study staff about available compensation.
Taking part in a clinical study is completely voluntary. If enrolled, you can choose to end your participation at any time and for any reason.
The study is sponsored by AstraZeneca, a pharmaceutical company that is committed to developing more environmentally friendly respiratory inhalers. The type of propellant being tested in this study would have less Global Warming Potential (GWP) than the kind of propellants currently used in respiratory medicines.1
1 AstraZeneca Pharmaceuticals. Data on File. Global Warming Potential of HFO-1234ze. (ID: REF-140251).
Time to complete: ~1-3 minutes